Ashwagandha vs Maca for PCOS: They Are Not the Same Choice
8 min read
A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.
The short answer
Ashwagandha and maca are sold as interchangeable “hormone balancers,” but they share no mechanism and no PCOS evidence — maca’s entire human trial record is just 4 studies, none in PCOS. The decision that matters is safety: ashwagandha’s thyroid interaction and pregnancy contraindication versus maca’s raw-form goitrogen caution — pick based on which one you can rule out.
Are Ashwagandha and Maca Actually the Same Kind of Supplement?
No. They are two unrelated plants, marketed with the same vague “hormone-balancing” language, with almost nothing else in common. Ashwagandha (Withania somnifera) is a nightshade-family root containing steroidal lactones called withanolides, studied mainly for lowering cortisol in stressed adults. Maca (Lepidium meyenii) is a Peruvian Brassica-family root that contains no measurable estrogenic or androgenic activity in the trials that tested for it directly, studied mainly for libido and mood in men and postmenopausal women. One is a hormone-axis modulator with a documented mechanism; the other contains no hormones at all and its mechanism is genuinely unclear. Selling both under the same “balances your hormones” pitch obscures that they would need to work in completely different ways even if either one did anything for PCOS specifically.
Does Either One Have PCOS Trial Evidence?
No. Zero published human trials have tested ashwagandha’s effect on menstrual cycles, ovulation, androgens, or insulin resistance in women with PCOS, and the same is true of maca: the two systematic reviews covering maca’s entire human trial record found only four qualifying randomized trials total, none of them in a PCOS population. That means the question “which one works better for PCOS” has no evidence on either side to answer it — this comparison exists to answer a different, more useful question: given that neither is proven, which one’s risks can you rule out first?
| Ashwagandha | Maca | |
|---|---|---|
| Plant family | Nightshade (Solanaceae) | Brassica / cabbage family |
| Contains hormones? | No, but modulates cortisol and thyroid hormone | No measurable estrogenic or androgenic activity found in testing |
| Best-studied outcome | Cortisol reduction in stressed, non-PCOS adults | Libido and menopausal symptom scores in non-PCOS adults |
| PCOS trial evidence | None | None |
| Typical studied dose | 240–600 mg standardized root extract daily | 1,500–3,000 mg gelatinised root daily |
Why the Thyroid Risk Is the Practical Crux for PCOS Readers Specifically
Ashwagandha and maca both carry a thyroid caution, but they are not the same caution, and the difference matters more here than on a general wellness site because Hashimoto’s thyroiditis is roughly 2.7 times more common in women with PCOS than in controls (odds ratio 2.69), pooled across 22 studies. A large share of readers comparing these two supplements are already managing a thyroid condition without realizing it is more likely, or already know they have one.
Ashwagandha’s thyroid effect is a documented, active interaction: an 8-week randomized trial found 600 mg daily significantly raised T3, T4, and improved TSH in people with subclinical hypothyroidism. That is a problem specifically if you take levothyroxine, because it means stacking a compound that pushes thyroid hormone up on top of a dose calibrated to a specific TSH target — a real interaction that can surface as heart palpitations, tremor, heat intolerance, or unintended weight loss over days to weeks, not a theoretical one.
Maca’s thyroid caution runs the opposite direction and depends on how it is processed. Raw maca contains glucosinolates that release thiocyanate and goitrin when crushed, and both compounds compete with iodine for thyroid uptake, a documented risk across the Brassica family maca belongs to — a caution about under-active thyroid function from a nutrient-competition mechanism, not an active drug-like interaction with a specific medication. Gelatinised maca’s heat processing plausibly reduces this risk but has not been tested for it directly.
| Ashwagandha | Maca (raw form) | |
|---|---|---|
| Direction of effect | Raises T3/T4, can push thyroid hormone too high | Competes with iodine, can suppress thyroid hormone synthesis |
| Mechanism | Direct hormonal modulation, shown in an RCT | Glucosinolate/iodine competition, general Brassica biology |
| Highest-risk group | People on levothyroxine or with Hashimoto’s | People with an iodine-marginal diet or undiagnosed hypothyroidism |
| Reduced by processing? | Not applicable | Gelatinisation plausibly reduces it; untested directly |
The Other Risk That Doesn’t Overlap: Pregnancy and Liver
Beyond the thyroid, the two supplements diverge again in ways that matter for different readers. Ashwagandha has no human pregnancy safety data at all — a 2026 review found the historical abortifacient claim is more overstated than the mechanism data support, but confirmed no trial has tested it in pregnancy either way — and it carries a dedicated NIH LiverTox entry for documented cases of liver injury, some of them in people taking it specifically while trying to conceive. Maca has neither of those signals in its trial record: no liver injury case series exists for it, and its human trials, while not run in pregnant women either, come from a plant with a long dietary history as a food staple rather than a documented hepatotoxin.
Who Should Avoid Which
| If you… | Avoid or flag first |
|---|---|
| Take levothyroxine or have Hashimoto’s | Ashwagandha |
| Are pregnant, breastfeeding, or trying to conceive | Ashwagandha |
| Have any liver disease | Ashwagandha |
| Have an undiagnosed thyroid issue or low-iodine diet | Raw maca (ask for gelatinised) |
| Have an autoimmune condition or take an immunosuppressant | Ashwagandha |
| None of the above apply | Neither has PCOS evidence either way — this is a preference decision, not an evidence-based one |
Do Not Expect a Winner Here
Neither ashwagandha nor maca has been shown to help PCOS specifically, and this article is not going to manufacture a winner where the trial evidence doesn’t support one. If neither risk category above applies to you, the honest answer is that you are choosing between two under-tested supplements based on cost, tolerability, or personal preference — not on evidence that either changes a PCOS outcome. If one risk category does apply to you, the decision has effectively already been made: rule out the one whose specific, documented risk you carry, not the one that sounds less effective.
You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. Nothing about the evidence or risk comparison above changes with the name — this article uses PCOS because that is still what most readers search.
Common questions
Is ashwagandha or maca better for PCOS?
Neither has a PCOS trial on cycles, androgens, or insulin, so there is no evidence that either works better. They also don't work the same way: ashwagandha modulates cortisol and thyroid hormone; maca contains no measurable hormones at all.Can I take ashwagandha and maca together?
No trial has tested the combination in anyone. They carry separate, non-overlapping risks — ashwagandha's liver and thyroid interactions, maca's raw-form goitrogen caution — so combining them adds both risk profiles rather than replacing one with the other.Which is safer for someone with thyroid disease?
It depends on the direction of your thyroid issue. Ashwagandha has a trial showing it raises T3/T4, a risk for anyone on levothyroxine or with Hashimoto's. Raw maca can compete with iodine and theoretically lower thyroid hormone output; gelatinised maca plausibly reduces this, though it hasn't been tested directly.Is maca safer than ashwagandha in pregnancy?
Ashwagandha has a specific, documented pregnancy gap and case reports of liver injury in people trying to conceive; maca's human trials also excluded pregnant women, but it carries no comparable liver-injury or abortifacient signal in its literature.Do ashwagandha and maca actually balance hormones?
Ashwagandha's own evidence is about lowering cortisol, not broadly 'balancing hormones.' Maca's key trial is literally titled around symptom improvement occurring without any hormone change. 'Hormone balancer' is the shared marketing term, not a shared, tested mechanism.
Your Next Step
If you take levothyroxine, have Hashimoto’s, or are trying to conceive, the full ashwagandha evidence and risk review has the case-series detail behind that caution. If a thyroid concern is what’s actually driving this comparison, the PCOS-thyroid overlap and what testing looks like is the more direct place to start. If you’re weighing either of these against something else you already take, the supplement interaction checker is faster than reading every label by hand — and the full maca evidence review covers what its own small trial record does and doesn’t show. Weighing ashwagandha against a different adaptogen instead? Ashwagandha vs holy basil runs the same risk-first comparison against tulsi.
- PCOS Supplement Routine: Morning vs Night, Per the TrialsNo PCOS trial tested a full morning-vs-night supplement routine. What each supplement's own trials actually specified, assembled into one realistic daily plan.
- Alpha-Lipoic Acid vs Berberine for PCOS: Different Jobs, Different EvidenceAlpha-lipoic acid and berberine are sold as interchangeable PCOS insulin sensitisers. Their mechanisms, evidence, and safety profiles are not the same.
- Ashwagandha for PCOS: The Real Evidence and the Real RisksNo PCOS trial has tested ashwagandha on cycles, androgens or insulin — only cortisol trials in people without it. The liver, thyroid and pregnancy risks.
- Ashwagandha vs Holy Basil for PCOS: Which Adaptogen Is Actually Safer?Neither has a PCOS trial. How ashwagandha's liver and thyroid risks compare to holy basil's antifertility and bleeding signals, so you can pick the safer one.
Sources
- 1.Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med. 2018.
- 2.Tallon MJ, Koturbash I, Blum JL. A Systematic and Ethnobotanical Review of Ashwagandha's (Withania somnifera) Teratogenic and Abortifacient Potentials. Phytother Res. 2026.
- 3.National Institute of Diabetes and Digestive and Kidney Diseases. Ashwagandha. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012.
- 4.Albalawi Y, Mirghani H. The crosstalk between polycystic ovary syndrome and Hashimoto thyroiditis: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2026.
- 5.Brooks NA, Wilcox G, Walker KZ, Ashton JF, Cox MB, Stojanovska L. Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause. 2008.
- 6.Felker P, Bunch R, Leung AM. Concentrations of thiocyanate and goitrin in human plasma, their precursor concentrations in brassica vegetables, and associated potential risk for hypothyroidism. Nutr Rev. 2016.
- 7.Shin BC, Lee MS, Yang EJ, Lim HS, Ernst E. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complement Altern Med. 2010.
- 8.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.